RGI-5000

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRGI-5000
Drug Alias NameRGI-5000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes modulators
TargetsEnzymes
Therapy Area/IndicationsImmune System DiseasesLysosomal Storage DiseasesHemophilia A +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegimmune Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegimmune Ltd
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesLysosomal Storage DiseasesHemophilia A +[4] 

Other Information

ATC CodeN/A
Related LinksN/A